Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Frequent multiple hepatitis C virus infections among injection drug users in a prison setting.

Pham ST, Bull RA, Bennett JM, Rawlinson WD, Dore GJ, Lloyd AR, White PA.

Hepatology. 2010 Nov;52(5):1564-72. doi: 10.1002/hep.23885.

PMID:
21038409
2.

Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam.

van de Laar TJ, Molenkamp R, van den Berg C, Schinkel J, Beld MG, Prins M, Coutinho RA, Bruisten SM.

J Hepatol. 2009 Oct;51(4):667-74. doi: 10.1016/j.jhep.2009.05.027. Epub 2009 Jun 18.

PMID:
19646773
3.

Hepatitis C virus infection among a cohort of Victorian injecting drug users.

Crofts N, Hopper JL, Bowden DS, Breschkin AM, Milner R, Locarnini SA.

Med J Aust. 1993 Aug 16;159(4):237-41.

PMID:
7692222
4.

Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.

Tanimoto T, Nguyen HC, Ishizaki A, Chung PT, Hoang TT, Nguyen VT, Kageyama S, Oka S, Pham VT, Ichimura H.

J Med Virol. 2010 Aug;82(8):1355-63. doi: 10.1002/jmv.21787.

PMID:
20572071
5.

Complex patterns of HCV epidemic in Suzhou: evidence for dual infection and HCV recombination in East China.

Du H, Qi Y, Hao F, Huang Y, Mao L, Ji S, Huang M, Qin C, Yan R, Zhu X, Zhang C.

J Clin Virol. 2012 Jul;54(3):207-12. doi: 10.1016/j.jcv.2012.04.017. Epub 2012 May 16.

PMID:
22595306
6.

Hepatitis C virus reinfection in injection drug users.

Grebely J, Conway B, Raffa JD, Lai C, Krajden M, Tyndall MW.

Hepatology. 2006 Nov;44(5):1139-45.

PMID:
17058216
7.

High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.

Micallef JM, Macdonald V, Jauncey M, Amin J, Rawlinson W, van Beek I, Kaldor JM, White PA, Dore GJ.

J Viral Hepat. 2007 Jun;14(6):413-8.

PMID:
17501762
8.

Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.

Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, Ncube F, Parry JV.

J Viral Hepat. 2011 Apr;18(4):262-70. doi: 10.1111/j.1365-2893.2010.01297.x.

PMID:
20456636
9.

High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.

Lehmann M, Meyer MF, Monazahian M, Tillmann HL, Manns MP, Wedemeyer H.

J Med Virol. 2004 Jul;73(3):387-91.

PMID:
15170633
10.

High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland.

Chlabicz S, Flisiak R, Kowalczuk O, Wiercińska-Drapalo A, Pytel-Krolczuk B, Prokopowicz D, Chyczewski L.

J Med Virol. 2008 Apr;80(4):615-8. doi: 10.1002/jmv.21107.

PMID:
18297715
11.

Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.

Schleicher S, Schieffer M, Jürgens S, Wehner HD, Flehmig B.

Ig Sanita Pubbl. 2005 Sep-Oct;61(5):435-50.

PMID:
17214028
12.

Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.

Verachai V, Phutiprawan T, Theamboonlers A, Chinchai T, Tanprasert S, Haagmans BL, Osterhaus AD, Poovorawan Y.

Southeast Asian J Trop Med Public Health. 2002 Dec;33(4):849-51.

PMID:
12757237
13.

Genotypic and epidemiologic characteristics of hepatitis C virus infections among recent injection drug user and nonuser populations.

Krekulova L, Rehak V, Madrigal N, Johnson M, Killoran P, Riley LW.

Clin Infect Dis. 2001 Oct 15;33(8):1435-8. Epub 2001 Sep 17.

PMID:
11565087
14.

Viral evolution of hepatitis C in injection drug users.

Dove L, Phung Y, Bzowej N, Kim M, Monto A, Wright TL.

J Viral Hepat. 2005 Nov;12(6):574-83.

PMID:
16255758
15.

Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users.

Anastassopoulou CG, Paraskevis D, Sypsa V, Psichogiou M, Katsoulidou A, Tassopoulos N, Skoutelis A, Malliori M, Hatzakis A.

J Med Virol. 1998 Nov;56(3):246-52.

PMID:
9783693
16.

A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus.

Currie SL, Ryan JC, Tracy D, Wright TL, George S, McQuaid R, Kim M, Shen H, Monto A.

Drug Alcohol Depend. 2008 Jan 11;93(1-2):148-54. Epub 2007 Oct 30. Erratum in: Drug Alcohol Depend. 2008 Jul;96(1-2):192.

PMID:
17977668
17.

Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort.

Post JJ, Pan Y, Freeman AJ, Harvey CE, White PA, Palladinetti P, Haber PS, Marinos G, Levy MH, Kaldor JM, Dolan KA, Ffrench RA, Lloyd AR, Rawlinson WD; Hepatitis C Incidence and Transmission in Prisons Study (HITS) Group..

J Infect Dis. 2004 May 15;189(10):1846-55. Epub 2004 Apr 26.

PMID:
15122521
18.

Molecular epidemiology of hepatitis C virus in a social network of injection drug users.

Aitken CK, McCaw RF, Bowden DS, Tracy SL, Kelsall JG, Higgs PG, Kerger MJ, Nguyen H, Crofts JN.

J Infect Dis. 2004 Nov 1;190(9):1586-95. Epub 2004 Sep 23.

PMID:
15478062
19.

Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.

Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG; Cyprus IVDU Network., Kostrikis LG.

J Med Virol. 2010 Feb;82(2):263-70. doi: 10.1002/jmv.21690. Erratum in: J Med Virol. 2010 May;82(5):910-1.

PMID:
20029809
20.

Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time.

Samimi-Rad K, Nasiri Toosi M, Masoudi-Nejad A, Najafi A, Rahimnia R, Asgari F, Shabestari AN, Hassanpour G, Alavian SM, Asgari F.

Arch Virol. 2012 Oct;157(10):1959-65. Epub 2012 Jun 13.

PMID:
22695769

Supplemental Content

Support Center